Nemera: Drug delivery devices

Celebrating our leaders, not with a rose, but with a voice.
The International Women’s day marks a call to action for accelerating women’s equality giving us the perfect opportunity to celebrate. Our colleagues across the globe share their thoughts on supporting women empowerment and women who inspire them or have contributed to who they are!
Read our employee testimonials
Nemera expands diabetes device portfolio and prepares for the future
In the latest 'The Pharmaceutical Post', Nemera is a leading designer and leading provider of injectable delivery systems, offering different pen and auto-injector platforms for the treatment of diabetes.
Read the article
Nemera CEO shares 2021 ambition
As the first month of the new year comes to a close, our CEO, Marc Hämel shares the lessons we learned from last year, extends his wishes, gratitude to the Nemera family and walks us through the top company goals that will shape and drive our story in 2021!
Watch the video

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology and generic industries

We leverage a long standing experience to provide you leading-edge drug delivery devices
for different application areas, from design to large scale manufacturing.

Device design & development

World Class Innovation Center: we are passionate to develop the best solutions
Learn more

100% quality focused manufacturing

Global GMP manufacturing capabilities and strong continuous improvement culture
Learn more

A wide range of drug delivery devices for every application

Ophthalmic Preservative-free multidose eye dropper
Ophthalmic
Nasal spray bioequivalence
Ear, Nose, Throat
Passive safety system for prefilled syringes
Parenteral
Airless dispenser for dermal topical delivery
Dermal
Inhaler for astham and COPD
Inhalation

Our latest news

Contact us

E-mail: [email protected]

This form collects your name and email so that we can send you your requested content. Check out our legal notices for more details.

Linkedin-in
Twitter
Youtube